NCT01132573 2014-07-17Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic LeukemiaNational Cancer Institute (NCI)Phase 1 Completed27 enrolled